Join a Legacy of Innovation 125 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
We are currently seeking a US Marketing Intern for the year (June 2025 – May 2026). This full time position works for approximately 37.5 hours per week.
Responsibilities:
The US Marketing, Hematology, Emerging Assets & TGCT Marketing intern is a valuable member of the commercial brand team and will play a critical role in assisting with the development of strategy, tactics and other pressing needs of the business. They will be accountable for assisting marketing partners with content creation and PMRT submission. Furthermore, they will assist marketing partners with LCM initiatives, congress strategy and execution as well as personal and NPP project management.
Education/Experience:
Qualified candidates must currently be enrolled in an accredited graduate program with a concentration in a marketing, healthcare or other business-related field. Prior experience in a corporate business environment is preferred; experience in the pharmaceutical/healthcare industry is a plus. Candidate should be detail oriented with the ability to engage in fast-paced projects. Understands how to work in Excel, Word and PowerPoint. Additionally, candidate must demonstrate the ability to collaborate, operate and influence cross-functionally with various internal/external associates.
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
What We Do
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.
